Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2009
10/21/2009CN101560245A CTL epitope polypeptide of avian influenza H5N1 virus and application thereof
10/21/2009CN101558899A Mongolian dandelion herb and probiotic fermented drink and preparation method thereof
10/21/2009CN101558896A Dahurian patrinia herb and probiotic fermented drink and preparation method
10/21/2009CN101558820A Production method for bioprotein feeding stuff
10/21/2009CN101558793A Preparation technology for producing lactobacillus starter culture by cheese
10/21/2009CN101558766A Trichoderma solid granules for preventing and controlling tobacco soil-borne fungus diseases and preparation method thereof
10/21/2009CN101558765A Biocontrol microbial inoculum for controlling cacac moth
10/21/2009CN101558764A Biocontrol microbial inoculum for controlling tobacco leaf stored grain insects
10/21/2009CN100552036C Method for the production of sulphur-containing fine chemicals by fermentation
10/21/2009CN100552029C Pichia pastoris omega3-fatty acid dehydrogenase promoter sequence and use thereof
10/21/2009CN100552023C Aminopeptidase
10/21/2009CN100552021C Process for storing methane oxidizing bacteria
10/21/2009CN100552020C Intensive production method for sulfur-free rhodospirillum
10/21/2009CN100552019C A Paracoccus denitrificans and its culturing method and application
10/21/2009CN100552018C Myxobacteria specific plasmid and its use
10/21/2009CN100552017C High efficiency nitrogen circulating bacteria artificial screening and application in aquatic ecological restoration and water treatment
10/21/2009CN100552016C Bifidobacterium in treatment of inflammatory disease
10/21/2009CN100552015C Yeast cell cracking method
10/20/2009USRE40940 DNA sequences from the K. lactis PGK gene having transcriptional promoter activity; expression vectors comprising these sequences and to their use for the production of proteins
10/20/2009US7605248 Recombinant constructs of Borrelia burgdorferi
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/20/2009US7605245 PUFA polyketide synthase systems and uses thereof
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605226 Meltrins
10/20/2009US7605115 Subtilisin variants
10/20/2009US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
10/20/2009US7604980 Protein expression system
10/20/2009US7604979 Method for producing an L-amino acid using a bacterium with an optimized level of gene expression
10/20/2009US7604978 Reducing or inhibiting a biofilm by modulating expression of a cysB gene present in a Gram-negative bacteria cell capable of biofilm formation; reducing infections
10/20/2009US7604976 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait
10/20/2009US7604975 Glycosylated LPXTGases and uses thereof
10/20/2009US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/20/2009US7604971 Sequence-determined DNA fragments encoding UBIE/COQ5 methyltransferase family proteins
10/20/2009US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus
10/20/2009US7604969 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence
10/20/2009US7604968 Microorganisms for the recombinant production of resveratrol and other flavonoids
10/20/2009US7604962 α-agarase and process for producing the same
10/20/2009US7604958 Transfection, culturing; electrophoresis
10/20/2009US7604809 Reinforcing systemic immune responses with lactobacillus casei
10/20/2009US7604807 Use of pullulan to isolate and preserve biological material
10/20/2009CA2376056C Mutant fatty acid desaturase and methods for directed mutagenesis
10/20/2009CA2330363C Diacylglycerol o-acyltransferase
10/20/2009CA2330183C Novel insulin analogs with enhanced zinc binding
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009WO2009126890A2 Production of carotenoids in oleaginous yeast and fungi
10/15/2009WO2009126719A2 Commensal bacteria as signal mediators within a mammalian host
10/15/2009WO2009126623A2 Expression of heterologous sequences
10/15/2009WO2009126463A2 Filamentous fungi with inactivated protease genes for altered protein production
10/15/2009WO2009125819A1 Aminosugar compound and process for production thereof
10/15/2009WO2009125646A1 Tdp-43-storing cell model
10/15/2009WO2009125462A1 Microorganism capable of decomposing aromatic compounds and method of decomposing aromatic compounds using the same
10/15/2009WO2009124694A2 Synthesis of polyunsaturated fatty acids in yeast
10/15/2009WO2009094636A3 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway
10/15/2009WO2009085935A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/15/2009WO2009079549A3 Inhibitors of bacterial nitric oxide synthase, and related screening methods
10/15/2009US20090259035 Method for producing recombinant RNase A
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258794 Apoptosis methods, genes and proteins
10/15/2009US20090258418 Reactive 1,3'-crosslinked carbocyanines and their bioconjugates
10/15/2009US20090258411 Centrifugal device and method for ova detection
10/15/2009US20090258410 Methods for producing soluble membrane spanning proteins
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258408 Method for the isolation of spiroplasma in mammals
10/15/2009US20090258407 Temperature transfer devices
10/15/2009US20090258402 L-Glutamic Acid Producing Bacterium and a Method for Production of L-Glutamic Acid
10/15/2009US20090258401 L-amino acid producing bacterium and method of producing l-amino acid
10/15/2009US20090258400 Mutant Tyrosine Repressor, a Gene Encoding the Same, and a Method for Producing L-Dopa
10/15/2009US20090258399 Method for production of amino acid
10/15/2009US20090258397 METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135
10/15/2009US20090258394 Method for the production of high-level soluble human recombinant interferon alpha in e. coli and vectors useful for such a production
10/15/2009US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
10/15/2009US20090258390 Prokaryotic collagen-like proteins and uses thereof
10/15/2009US20090258389 Construction of New Variants of Dextransucrase DSR-S by Genetic Engineering
10/15/2009US20090258388 Methods of enhanced heterologous protein secretion
10/15/2009US20090258379 Isolation of membrane vesicles from biological fluids and methods of using same
10/15/2009US20090258366 pCryptoRNAi
10/15/2009US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders
10/15/2009US20090258051 Microbes Encapsulated Within Crosslinkable Polymers
10/15/2009US20090258037 Vaccine development strategy using microgravity conditions
10/15/2009US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
10/15/2009US20090258015 Modulators of Candida Hyphal Morphogenesis and Uses Thereof
10/15/2009US20090258007 Anti-Perp Antibody
10/15/2009US20090257995 Harmful bacterium control agent containing bacillus thuringiensis
10/15/2009US20090257993 Lactic Acid Producing Bacteria and Lung Function
10/15/2009CA2758023A1 Commensal bacteria as signal mediators within a mammalian host
10/15/2009CA2721051A1 Aminosugar compound and process for production thereof
10/15/2009CA2720828A1 Direct chemical modification of microbial biomass and microbial oils
10/15/2009CA2720827A1 Filamentous fungi with inactivated protease genes for altered protein production
10/15/2009CA2719923A1 Expression of heterologous sequences
10/14/2009EP2108702A1 Synthesis of polyunsaturated fatty acids in yeast
10/14/2009EP2108697A1 Improved methods of in vitro protein systhesis
10/14/2009EP2108694A1 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation
10/14/2009EP2108693A2 Microorganism producing L-methionine precursor and the method of producing L-methionone precursor using the microorganism
10/14/2009EP1539948B1 Improved methods of in vitro protein synthesis
10/14/2009EP1506995B1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith
10/14/2009EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009EP1379126B1 Novel endophytic fungi and methods of use
10/14/2009EP1356046B1 Cytokine receptor zcytor19